Brain Aging

Plasma p-tau217 Blood Test Predicts Alzheimer’s Symptom Onset within 3 Years (2026 Research)

by

Blood Test Predicts Alzheimer’s 3-4 Years Early TL;DR: A blood test measuring phosphorylated tau-217 can predict when cognitively normal people will develop Alzheimer’s symptoms with a 3.0-3.7 year margin of error, potentially transforming how researchers identify candidates for preventive clinical trials. For decades, Alzheimer’s disease remained invisible until symptoms emerged. Brain scans could show amyloid …

Read more

New Blood Test Detects Alzheimer’s Disease with 83% Accuracy Years Before Symptoms

by

Blood Test Detects Alzheimer’s with 83% Accuracy TL;DR: A new blood test using three misfolded plasma proteins can identify Alzheimer’s disease with 83.44% accuracy, outperforming conventional biomarkers and offering a non-invasive screening tool years before cognitive symptoms appear. The holy grail of Alzheimer’s research isn’t a cure—yet. It’s catching the disease before memory starts to …

Read more

The Glymphatic System vs. Brain Health & Impact of Exercise & Sleep (2024 Research)

by

Researchers reviewed the potential impacts of physical exercise on the glymphatic system and its implications for neurodegenerative diseases, focusing on the mechanisms involved and the interplay between exercise and sleep quality. Highlights: The glymphatic system, a brain cleansing mechanism, may play a critical role in the development of neurodegenerative diseases by clearing metabolic waste, including …

Read more

Hypertension Linked to Impaired Cognition & Gait in Older Adults (2024 Study)

by

Hypertension in older adults leads to poorer cognitive and walking performance due to the need for more brain resources to manage dual tasks. Highlights: Older adults with hypertension show higher brain activation in motor and sensory areas when performing dual cognitive-walking tasks compared to healthy peers. Hypertensive individuals have worse cognitive performance on single cognitive …

Read more

Age-Related Brain Volume Changes in Men & Women (2024 MRI Study)

by

Normal aging leads to a decrease in brain volume, with gray and white matter shrinking and cerebrospinal fluid increasing, as measured by synthetic MRI. Highlights: Study Sample: 300 healthy adults (141 males, median age 48; 159 females, median age 50) were analyzed using synthetic MRI. Brain Volume Trends: Brain parenchymal volume (nBPV) decreases steadily with …

Read more

Cocaine Destroys Gray Matter & Accelerates Brain Aging

by

Cocaine use can lead to significant structural changes and accelerated aging of the brain, according to a new study. Key findings include: Cocaine users showed widespread gray matter loss in areas involved in emotions, language, cognition and decision-making. Cocaine users had “older” looking brains, with brain-predicted age 2.5 years higher than their real age. Brain …

Read more

High Rates of Pineal Gland Calcification & Possible Health Effects

by

Pineal gland calcification, the buildup of calcium deposits in the pineal gland, is surprisingly common, affecting over 60% of the population according to a new meta-analysis. This concerning condition can disrupt proper pineal gland functioning and melatonin secretion, potentially contributing to an array of health issues. Key Facts: The pineal gland regulates circadian rhythms through …

Read more

Medium Chain Triglycerides Boost Cognition & Memory in Healthy Older Adults

by

A new systematic review published in BMC Geriatrics suggests that supplementing with medium-chain triglycerides (MCTs) may provide cognitive benefits for older adults without dementia. MCTs are a type of fatty acid found in foods like coconut oil and palm kernel oil that may help provide the brain with an alternative energy source. Key Facts: MCT …

Read more

Medium Chain Triglycerides (MCTs) for Alzheimers Disease: Benefits for APOE e4(-) Patients?

by

Alzheimer’s disease (AD) is a growing global health concern, but current drug therapies have shown limited effectiveness for symptom management and disease modification. Medium chain triglycerides (MCTs) have emerged as a potential nutritional therapy, but evidence remains inconclusive. Key Facts: MCTs may provide an alternative brain fuel source and reduce AD biomarkers like amyloid-beta. Small …

Read more

Dopamine in Parkinsons Disease: Insights & Future Therapies

by

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopamine-producing neurons. Dopamine plays an important role in PD development. Here are some key facts: Dopamine is a chemical messenger in the brain involved in movement, motivation, and mood. Loss of dopamine-producing neurons causes the motor symptoms of PD like tremors, rigidity, and …

Read more

+ Load more